SCHEMBL13486629

SCHEMBL13486629

COc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 9/20 0.72
▸ ADRA2A P08913 1/20 0.71
▸ ADRA1D P25100 1/20 0.71
▸ PKM P14618 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ HDAC1 Q13547 2/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC9 Q9UKV0 1/20 0.48
▸ HDAC5 Q9UQL6 1/20 0.48
▸ MAPT P10636 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3208982 0.85 HRH3 (0.72) HRH3ADRA2AADRA1DHDAC1HDAC6
SCHEMBL3192212 0.84 HRH3 (1.00) HRH3ADRA2AADRA1D
Dispyrin SCHEMBL3216423 0.83 HRH3 (1.00) HRH3ADRA2AADRA1D
SCHEMBL13486628 0.83 HRH3 (0.62) HRH3ADRA2AADRA1DPKMALDH1A1
SCHEMBL3199073 0.80 HRH3 (1.00) HRH3ADRA2AADRA1D
SCHEMBL3190539 0.79 HRH3 (1.00) HRH3ADRA2AADRA1D
SCHEMBL15319511 0.79 CA12 (0.56) ALDH1A1HDAC1HDAC6MAPTMEN1
SCHEMBL3996984 0.79 SMN1; SMN2 (0.59) ALDH1A1HDAC1HDAC6MAPTHPGD
SCHEMBL3780865 0.79 HDAC1 (0.59) ALDH1A1HDAC1HDAC6MAPTMEN1
SCHEMBL3208873 0.78 HRH3 (0.72) HRH3ALDH1A1HDAC1HDAC6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 — — US disclosed
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 — — US disclosed
WO-2009152071-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY (US) 2009-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF HRH3, HRH4, HRH1 HRH3 1/4885ADRA2A 252/4885ADRA1D 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback